National Asset Management, Inc. Athenex, Inc. Transaction History

National Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	BUY	$0.12 - $0.21 $1,440 - $2,520	12,000 Added 2.89%	426,549 $63,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $5,057 - $23,392	21,074 Added 5.36%	414,549 $112,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $1,127 - $2,502	-2,750 Reduced 0.69%	393,475 $162,000
Q1 2022 May 02, 2022	BUY	$0.79 - $1.59 $13,145 - $26,457	16,640 Added 4.38%	396,225 $329,000
Q4 2021 Jan 28, 2022	SELL	$1.36 - $2.94 $13,266 - $28,679	-9,755 Reduced 2.51%	379,585 $517,000
Q2 2021 Aug 10, 2021	SELL	$3.71 - $5.13 $1.26 Million - $1.74 Million	-338,595 Reduced 46.51%	389,340 $1.8 Million
Q1 2021 May 13, 2021	BUY	$4.08 - $14.75 $2.97 Million - $10.7 Million	727,935 New	727,935 $3.13 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.